Alerts will be sent to your verified email
Verify Email
ERIS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Eris Lifesciences Limited, founded in 2007, is a fast-growing company in the Indian Branded Formulations market, focusing on cardiovascular, anti-diabetes, vitamins, gastroenterology, and gynecology products.
Eris Lifesciences major competitors are Pfizer, Wockhardt, JB Chem & Pharma, Astrazeneca Pharma I, Alembic Pharma, Gland Pharma, Ajanta Pharma.
Market Cap of Eris Lifesciences is ₹24,226 Crs.
While the median market cap of its peers are ₹23,498 Crs.
Eris Lifesciences seems to be less financially stable compared to its competitors.
Altman Z score of Eris Lifesciences is 4.93 and is ranked 8 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | May Jun Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||
| Conference Call | Jun | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
